ReviewInternational journal of hematology2024

Evaluation of the pathogenic potential of germline DDX41 variants in hematopoietic neoplasms using the ACMG/AMP guidelines.

Hirotaka Matsui et al.PubMed ↗Publisher ↗

No numbers read from the abstract.